Rodolfo Herrera, MD
Family Medicine · Bedford, TXNPI 1154524668
Payments from drug & device makers
What this record shows
The money is spread across several categories — gifts (56.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. AbbVie accounts for 60.2% of it on its own, with 47 other manufacturers making up the rest. Reporting peaked in 2020 at $11,575 and has fallen 78.3% since, to $2,508 in 2025. Among family medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 358 payments — averaging $54.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$12K
- Spinal Simplicity, LLC$1K
- Abbott$1K
- Genesys Orthopedics Systems, L.L.C.$770
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$707
- Medtronic$435
- plus $3K from 42 others
Across 8 payments — averaging $1447.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Orasure Technologies Inc.$9K
- Lumos Diagnostics, Inc.$2K
- Roche Molecular Systems, Inc.$632
What the payments were for
- Travel & lodging$1,5608%
- Food & beverage$6,67434%
- Education$1531%
- Gifts$11,05557%
- Entertainment$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX COSMETIC$11,040
- KYBELLA$11,040
- HA MINUTEMAN G3-R$1,063
- SACROILIAC JOINT FUSION SYSTEM$646
- INTELLIS$216
- XEOMIN$200
- ASCLERA$200
- LIBERTY SI$176
- PATRIOT SI$176
- OCTRODE$153
- Proclaim Family of SCS IPGs$136
How this compares
$19,460 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 560 | $137,439 |
| BelbucaBuprenorphine Hcl | 169 | $135,329 |
| Nucynta ErTapentadol Hcl | 85 | $118,311 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 2,870 | $105,964 |
| Diclofenac Sodium | 109 | $85,557 |
| Diclofenac Epolamine | 26 | $48,824 |
| Lidocaine | 210 | $37,771 |
| LinzessLinaclotide | 53 | $30,527 |
| RelistorMethylnaltrexone Bromide | 12 | $28,871 |
| NucyntaTapentadol Hcl | 12 | $21,483 |
| Xtampza ErOxycodone Myristate | 27 | $19,405 |
| RoxybondOxycodone Hcl | 11 | $19,348 |
| Naproxen Sodium ErNaproxen Sodium | 13 | $18,756 |
| Cyclobenzaprine Hcl | 423 | $13,360 |
| Pregabalin | 549 | $13,307 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Nucynta Er, Nucynta, Xtampza Er | $262 | $294,527293 claims |
| Hikma Pharmaceuticals USABuprenorphine, Buprenorphine-Naloxone | $114 | $139,071582 claims |
| AbbVieLinzess | $11,717 | $30,52753 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $707 | $28,87112 claims |
| Protega Pharmaceutials IncRoxybond | $23 | $19,34811 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $20 | $5,65511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,760 family medicine providers in Texas.
Other family medicine in Bedford
- Carlos CamposNew Braunfels$1.5M
- Aaron KingSan Antonio$1.1M
- Bradley WassonArlington$734K
- Cynthia BrinsonAustin$402K
- Michael MendezLubbock$368K
- Sang Tae KimAmarillo$368K
- Sumit PerakathuHarlingen$342K
- Joel SolisMcAllen$324K
- Robert CampbellFort Worth$318K
- Jose LedezmaEdinburg$300K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.